FDA Inspection 1210223 — Ajanta Pharma Limited

Ajanta Pharma Limited — FEI 3012664809

The FDA completed an inspection of Ajanta Pharma Limited on Jun 23, 2023 in Bharuch. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 23, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bharuch (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.